Recent

% | $
Quotes you view appear here for quick access.

Aeterna Zentaris Inc. Message Board

  • lilduckdong lilduckdong Feb 15, 2013 9:17 PM Flag

    Why are many so-called 'analysts'

    focusing on Perifosine? I'd like to see progressive news on 108. That seems to be the real gem here. If the company gets a favorable independent review on Perifosine then just license it out again....this time to a bigger pharma and focus on 108.

 
AEZS
0.18160.0000(0.00%)Aug 3 3:59 PMEDT